News
The FDA approved a new ketamine (KETARx, PharmaTher) for the treatment of surgical pain management. The FDA previously issued a pair of complete response letters for the application in 2024, citing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback